We are thrilled to announce that LIVERSTAT, our software as medical device (SaMD) has been officially listed as a Class A Medical Device by the Health Sciences Authority (HSA). This significant milestone marks a pivotal moment in our journey to revolutionize liver disease management.
LIVERSTAT utilizes data from common blood biomarkers and anthropometrics to provide valuable insights into patient liver condition and can be used by clinicians to supplement clinical management for suspected liver disease.
We extend our heartfelt gratitude to the Fibronostics team for their dedication and hard work, which has been instrumental in achieving this remarkable feat. Additionally, we express our sincere appreciation to our partners for their unwavering support throughout this journey.
It’s important to note that while LIVERSTAT has been listed as a Class A Medical Device by the HSA, we acknowledge the disclaimer provided by the Health Sciences Authority.
We remain committed to upholding the highest standards of accuracy and integrity in our pursuit of advancing liver disease management.
Thank you to everyone who has been part of this incredible journey. Together, we are making a meaningful impact in the field of healthcare.
Notified HSA Class A Medical Device:
License number: ES0502495 or search LIVERSTAT
#HealthcareInnovation #LIVERSTAT #MedicalDevice #FibronosticsTeam #SaMD
